Strides Pharma gets USFDA nod for generic drug

Bengaluru-based Strides Pharma has 127 cumulative abbreviated new drug applications (ANDA) filings with USFDA of which 96 have been approved and 31 are pending approval.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3c8vaSx
via IFTTT